Stay updated on Cabozantinib vs Paclitaxel in Ovarian Cancer Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib vs Paclitaxel in Ovarian Cancer Clinical Trial page.

Latest updates to the Cabozantinib vs Paclitaxel in Ovarian Cancer Clinical Trial page
- Check7 days agoChange DetectedThe page revision tag was updated from v3.6.3 to v3.6.4, indicating a small behind-the-scenes update to the site. This does not alter the study details or visible content.SummaryDifference0.0%

- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedThe page's revision tag was updated from v3.6.2 to v3.6.3, indicating a new version of the page content. This appears to be a minor, administrative update rather than a substantive change to study information.SummaryDifference0.0%

- Check35 days agoChange DetectedThe page now displays Revision: v3.6.2, replacing the previous Revision: v3.6.0. This indicates an updated version of the page text and metadata.SummaryDifference0.0%

- Check50 days agoChange DetectedRecruitment status now states that enrollment is closed. The update also adds help and navigation sections, refines a label, and updates the revision tag to v3.6.0.SummaryDifference0.2%

- Check57 days agoChange DetectedThe page revision tag was updated from v3.5.4 to v3.5.5, indicating a minor version update to the page. It does not modify study details or visible content.SummaryDifference0.0%

- Check78 days agoChange Detected- The page now shows a new Revision: v3.5.4, replacing the prior v3.5.3, indicating a software version bump. This change reflects an internal update to the site rather than a modification to study information.SummaryDifference0.0%

Stay in the know with updates to Cabozantinib vs Paclitaxel in Ovarian Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib vs Paclitaxel in Ovarian Cancer Clinical Trial page.